Genome-wide association studies identified FXR1 as a risk variant for schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics, 2014), and FXR1 mRNA levels are reduced in postmortem brain in some individuals with schizophrenia and bipolar disorders (Shen et al., 2021). Here, FXR1 is linked to bipolar disorder.